Physician profile
David M Barrere
NPI 1295742401
$3,220.80
in general payments reported to CMS, 2019-2025
19 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $249 · 2021: $1,352 · 2022: $660 · 2023: $364 · 2024: $200 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $812.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $939.16 | 2021-2022 | |
| Gynesonics, INC. | $637.22 | 2021-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $637.16 | 2019-2025 | Liletta |
| Pfizer INC. | $190.43 | 2019-2024 | |
| Hologic Sales and Service, LLC | $150.03 | 2019-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Sage Therapeutics, LLC | $104.98 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $91.09 | 2021-2023 | Twirla |
| Therapeuticsmd, INC. | $87.80 | 2019-2020 | |
| Astellas Pharma US INC | $67.72 | 2024-2025 | Veozah |
| Channel Medsystems, INC. | $52.24 | 2023 | |
| Exeltis, USA INC. | $44.35 | 2022-2025 | Slynd |
| Novo Nordisk INC | $43.73 | 2025 | Wegovy |
| Dexcom, INC. | $41.88 | 2023-2025 | Dexcom G6 Transmitter |
| Coloplast Corp | $29.72 | 2021 | |
| Gilead Sciences, INC. | $27.82 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $23.50 | 2022 | |
| Acella Pharmaceuticals, LLC | $21.05 | 2025 | NP Thyroid 60 |
| Exact Sciences Corporation | $20.09 | 2023 | Cologuard Collection Kit |
| Coopersurgical, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Barrere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.